Alirocumab plus cemiplimab in immuno-refractory metastatic NSCLC: A single-arm, multi-center, phase 2 study.
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Eziafa Oduah, Andreas Nicholas Saltos, Tom Stinchcombe, Joel Rivera Concepcion, Jeffrey Crawford, Jeffrey Melson Clarke, Laura Alder, Cameron Oswalt, Steven Wolf, Sin-Ho Jung, Kouros Owzar, Xiaodi Qin, Abbie Ireland, Alan Chen, Liliana Lyniv, Neal E. Ready, Jhanelle E. Gray, Trudy G. Oliver, Scott Joseph Antonia
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7162535192
Cites:
Cited by:
Related to: